Abstract
BackgroundCAR T-cells show remarkable efficacy against B-cell malignancies with uniformly high expression of target antigens. In contrast, tumors with low/heterogenous antigen expression often evade CAR-T cytotoxicity and necessitate multi-antigen targeting...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
